Can procalcitonin predict bone infection in people with diabetes with infected foot ulcers? A pilot study

Diabetes Research and Clinical Practice

Volumn 94, Issue 1, 2011, Pages 53-56

  Mutluoĝlu, Mesut ^a   Uzun, Günalp ^a   Ipcioĝlu, Osman M ^a   Sildiroglu, Onur ^a   Özcan, Ömer ^a   Turhan, Vedat ^a   Mutlu, Hakan ^a   Yildiz, Senol ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Bone infection; Diabetic foot; Diagnostic accuracy; Infection marker

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC FOOT; DISEASE MARKER; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LEUKOCYTE COUNT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; PILOT STUDY; PREDICTIVE VALUE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; WOUND;

AGED; C-REACTIVE PROTEIN; CALCITONIN; DIABETES COMPLICATIONS; DIABETIC FOOT; FEMALE; FOOT ULCER; HUMANS; LEUKOCYTE COUNT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OSTEOMYELITIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS;

EID: 80054883665     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.05.023     Document Type: Article

References (24)

1. Lavery L.A., Wunderlich R.P., Tredwell J.L. Disease management for the diabetic foot: effectiveness of a diabetic foot prevention program to reduce amputations and hospitalizations. Diabetes Res Clin Pract 2005, 70:31-37.
2. Miyajima S., Shirai A., Yamamoto S., Okada N., Matsushita T. Risk factors for major limb amputations in diabetic foot gangrene patients. Diabetes Res Clin Pract 2006, 71:272-279.
3. Thomas R., Brenton K., Harris B., et al. Foot ulceration in a secondary care diabetic clinic population: a 4-year prospective study. Diabetes Res Clin Pract 2010, 90:e37-e39.
4. Ramsey S.D., Newton K., Blough D., et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 1999, 22:382-387.
5. Lavery L.A., Armstrong D.G., Wunderlich R.P., Mohler M.J., Wendel C.S., Lipsky B.A. Risk factors for foot infections in individuals with diabetes. Diabetes Care 2006, 29:1288-1293.
6. Oyibo S.O., Jude E.B., Tarawneh I., et al. The effects of ulcer size and site, patient's age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers. Diabet Med 2001, 18:133-138.
7. Lipsky B.A. Bone of contention: diagnosing diabetic foot osteomyelitis. Clin Infect Dis 2008, 47:528-530.
8. Lavery L.A., Peters E.J., Armstrong D.G., Wendel C.S., Murdoch D.P., Lipsky B.A. Risk factors for developing osteomyelitis in patients with diabetic foot wounds. Diabetes Res Clin Pract 2009, 83:347-352.
9. Dinh T., Snyder G., Veves A. Current techniques to detect foot infection in the diabetic patient. Int J Low Extrem Wounds 2010, 9:24-30.
10. Snider R.H., Nylen E.S., Becker K.L. Procalcitonin and its component peptides in systemic inflammation and sepsis: immunochemical investigation. J Investig Med 1997, 45:552-560.
11. Müller B., Becker K.L. Procalcitonin: how a hormone became a marker and mediator of sepsis. Swiss Med Wkly 2001, 131:595-602.
12. Uzun G., Solmazgul E., Curuksulu H., et al. Procalcitonin as a diagnostic aid in diabetic foot infections. Tohoku J Exp Med 2007, 213:305-312.
13. Lipsky B.A., Berendt A.R., Deery H.G., et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2004, 39:885-910.
14. Williams D.T., Hilton J.R., Harding K.G. Diagnosing foot infections in diabetes. Clin Infect Dis 2004, 39:S83-S86.
15. Jeandrot A., Richard J.L., Combescure C., et al. Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study. Diabetologia 2008, 51:347-352.
16. Butbul-Aviel Y., Koren A., Halevy R., Sakran W. Procalcitonin as a diagnostic aid in osteomyelitis and septic arthritis. Pediatr Emerg Care 2005, 21:828-832.
17. Faesch S., Cojocaru B., Hennequin C., et al. Can procalcitonin measurement help the diagnosis of osteomyelitis and septic arthritis? A prospective trial. Ital J Pediatr 2009, 35:33.
18. Eneroth M., Larsson J., Apelqvist J. Deep foot infections in patients with diabetes and foot ulcer: an entity with different characteristics, treatments, and prognosis. J Diabetes Complications 1999, 13:254-263.
19. Ertugrul B.M., Savk O., Ozturk B., Cobanoglu M., Oncu S., Sakarya S. The diagnosis of diabetic foot osteomyelitis: examination findings and laboratory values. Med Sci Monit 2009, 15(6):CR307-CR312.
20. Fleischer A.E., Didyk A.A., Woods J.B., Burns S.E., Wrobel J.S., Armstrong D.G. Combined clinical and laboratory testing improves diagnostic accuracy for osteomyelitis in the diabetic foot. J Foot Ankle Surg 2009, 48:39-46.
21. Kaleta J.L., Fleischli J.W., Reilly C.H. The diagnosis of osteomyelitis in diabetes using erythrocyte sedimentation rate: a pilot study. J Am Podiatr Med Assoc 2001, 91:445-450.
22. Kapoor A., Page S., Lavalley M., Gale D.R., Felson D.T. Magnetic resonance imaging for diagnosing foot osteomyelitis: a meta-analysis. Arch Intern Med 2007, 167:125-132.
23. Jeffcoate W.J., Lipsky B.A. Controversies in diagnosing and managing osteomyelitis of the foot in diabetes. Clin Infect Dis 2004, 39(Suppl. 2):S115-S122.
24. Enderle M.D., Coerper S., Schweizer H.P., et al. Correlation of imaging techniques to histopathology in patients with diabetic foot syndrome and clinical suspicion of chronic osteomyelitis. The role of high resolution ultrasound. Diabetes Care 1999, 22:294-299.